$HPPI Inhibitor Therapeutics, Inc. Insider Trading Week 10/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inhibitor Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Inhibitor Therapeutics, Inc. in week 10/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 200,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 400,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 79,200 | 26,928 | 553,600 | 632.8 K to 553.6 K (-12.52 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 200,000 | 0 | 632,800 | 432.8 K to 632.8 K (+46.21 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 158,400 | 53,856 | 432,800 | 591.2 K to 432.8 K (-26.79 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 400,000 | 0 | 591,200 | 191.2 K to 591.2 K (+209.21 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 191,200 | 310 K to 191.2 K (-38.32 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 300,000 | 0 | 310,000 | 10 K to 310 K (+3,000.00 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | M | 0.00 | 3,500,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | M | 0.00 | 3,500,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Payment of Exercise | F | 0.34 | 1,470,478 | 499,963 | 4,059,044 | 5.5 M to 4.1 M (-26.59 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Buy | M | 0.00 | 3,500,000 | 0 | 5,529,522 | 2 M to 5.5 M (+172.45 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Payment of Exercise | F | 0.34 | 1,470,478 | 499,963 | 2,029,522 | 3.5 M to 2 M (-42.01 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Buy | M | 0.00 | 3,500,000 | 0 | 3,500,000 | 0 to 3.5 M |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Option Exercise | M | 0.00 | 15,041,738 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Payment of Exercise | F | 0.34 | 6,314,219 | 2,146,834 | 8,727,519 | 15 M to 8.7 M (-41.98 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Buy | M | 0.00 | 15,041,738 | 0 | 15,041,738 | 0 to 15 M |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Buy | M | 0.00 | 300,000 | 0 | 600,000 | 300 K to 600 K (+100.00 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Buy | M | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 150,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 59,400 | 20,196 | 453,000 | 512.4 K to 453 K (-11.59 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 150,000 | 0 | 512,400 | 362.4 K to 512.4 K (+41.39 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 362,400 | 481.2 K to 362.4 K (-24.69 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 300,000 | 0 | 481,200 | 181.2 K to 481.2 K (+165.56 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 181,200 | 300 K to 181.2 K (-39.60 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |